Purdue Pharma L.P.
Major Drugs - Stamford, Connecticut, US
Purdue Pharma L.P. Employees
Jennifer Erensen
Executive Director, Medical Affairs Strategic Research/HEOR
Purdue Pharma L.P. Senior Management
Purdue Pharma L.P. Details
Purdue Pharma’s bankruptcy case was heard before the Supreme Court of the United States in December 2023. In June 2024, the Court voted 5-4 against third-party releases contained in the Plan of Reorganization. The decision does nothing to deter us from the twin goals of using settlement dollars for opioid abatement and turning the company into an engine for good. We are reaching back out to creditors and renewing our pursuit of a resolution that delivers billions of dollars of value for opioid abatement and allows the Company to emerge from bankruptcy as a company with a public-minded mission. The Supreme Court’s decision does not affect Purdue’s operational stability or our ability to produce medications safely and effectively. We continue to operate fully, honoring our existing relationships and meeting our obligations to our partners and customers. The company will continue serving patients who rely on our medicines, and working to introduce new medicines that will help save and improve lives.
Purdue Pharma L.P. Technologies
Email Providers
Outlook
Data Management Platform
Bluekai
Customer Relationship Management
Salesforce
Domain Name Services
Route 53
Other
Microsoft Office 365
Hosting
Amazon AWS